Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studies... Read more.
Gloo Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares
BOULDER, Colo., Nov. 24, 2025 /PRNewswire/ — Gloo Holdings, Inc., a technology platform serving the faith and flourishing ecosystem, today announced that in... Read more.
Evolve acquires Guestworks portfolio from Vacasa in strategic asset transaction
DENVER, Nov. 24, 2025 /PRNewswire/ — Evolve today announced the acquisition of Guestworks, operated by Vacasa, a Casago company, in an asset purchase transaction.... Read more.
SABIO REPORTS Q3 2025 RESULTS – CONTINUED CORE BRANDED BUSINESS GROWTH IN A NON-POLITICAL YEAR
Ad-supported streaming gross revenue up year-over-year when excluding political and advocacy. Early programmatic scale and international expansion drove nearly 40%... Read more.
Tuya Reports Third Quarter 2025 Unaudited Financial Results
SANTA CLARA, Calif., Nov. 24, 2025 /PRNewswire/ — Tuya Inc. (“Tuya” or the “Company”) (NYSE: TUYA; HKEX: 2391), a global leading... Read more.
Bed Bath & Beyond Enters into Merger Agreement to Acquire The Brand House Collective
Combination expected to create a more profitable, cost efficient, customer-focused retailer MURRAY, Utah and NASHVILLE, Tenn., Nov. 24, 2025 /PRNewswire/ —... Read more.
NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS
HOUSTON, Nov. 24, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated... Read more.
Match Group to Present at the Raymond James TMT & Consumer Conference
LOS ANGELES, Nov. 24, 2025 /PRNewswire/ — Match Group (NASDAQ: MTCH) announced today that Jackie Jantos, President & Chief Marketing Officer of Hinge,... Read more.
AMGEN TO PRESENT AT CITI’S 2025 GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Nov. 24, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at Citi’s 2025 Global Healthcare Conference at 1:45 p.m. ET on December... Read more.
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
CAMBRIDGE, Mass., Nov. 24, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted... Read more.